Concepedia

Andrew Haynes

AH

Statistics

Publications

17

Citations

1.9K

H-Index

16

Active since

2002

Affiliations

Nottingham City Hospital(Current)

King's College Hospital

Nottingham University Hospitals NHS Trust

Leeds General Infirmary

The University of Melbourne

Andrew Haynes is an author at Nottingham City Hospital specializing in immunotherapy, medicine, and immunology.

Top concepts

Publications per year

2002–2018

17

Publications

17

Eradication of Minimal Residual Disease in B-Cell Chronic Lymphocytic Leukemia After Alemtuzumab Therapy Is Associated With Prolonged Survival

Paul Moreton, Ben Kennedy, Guy Lucas et al. · Journal of Clinical Oncology · 2005 · 421 citations

Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma

Sharon Barrans, Ian Carter, Roger G. Owen et al. · Blood · 2002 · 280 citations · Full text

BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients

Rowena D. Faulkner, Charles Craddock, Prem Mahendra et al. · Blood · 2003 · 166 citations · Full text

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 152 citations · Full text

, , +7

The t(14;18) is associated with germinal center-derived diffuse large B-cell lymphoma and is a strong predictor of outcome.

Sharon Barrans, Paul Evans, Sheila J.M. O’Connor et al. · PubMed · 2003 · 138 citations

, , +16

1–5 of 17